BSECompany UpdateResults4h ago
IOL Chemicals & Pharmaceuticals Ltd
Communication to the Shareholders regarding AGM Notice ansd Annual Report for the Financial Year 2025-26
IOL Chemicals & Pharmaceuticals Ltd has announced the notice of its 39th Annual General Meeting (AGM) and the Integrated Annual Report for the financial year 2025-26. The AGM will be held on September 2, 2026, through video conferencing. The annual report is available on the company's website and on the websites of the stock exchanges where the company's securities are listed.
BSECompany UpdateResults5h ago
IOL Chemicals & Pharmaceuticals Ltd
Submission of newspaper publication of unaudited Financial Results for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd has submitted the newspaper publication of unaudited financial results for the quarter ended 30th June 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSECompany Update▲ PositiveResults1d ago
IOL Chemicals & Pharmaceuticals Ltd
Press Release- Financial Results for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd reported its Q1 FY27 results, with revenue from operations increasing 37.1% YoY to ₹756.3 Cr, EBITDA rising 60.7% YoY to ₹111.7 Cr, and PAT increasing 89.9% YoY to ₹64.5 Cr. The company's Pharmaceuticals business saw a 43% YoY revenue growth and 72% YoY EBIT growth, driven by improved capacity utilisation, favourable product mix, and operational efficiencies.
BSEResultResults1d ago
IOL Chemicals & Pharmaceuticals Ltd
Submission of Unaudited Financial Results of the Company for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with revenue from operations at ₹756.26 crore and profit before exceptional items and tax at ₹86.77 crore.
BSEBoard MeetingResults1d ago
IOL Chemicals & Pharmaceuticals Ltd
Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with a profit before exceptional items and tax of ₹86.77 crore, a decline from ₹70.83 crore in the previous quarter.
BSECompany UpdateResults3d ago
IOL Chemicals & Pharmaceuticals Ltd
Copy of notice published in Newspapers
IOL Chemicals & Pharmaceuticals Ltd has published a notice in newspapers regarding the 39th Annual General Meeting (AGM) and e-voting information. The company has sent the AGM notice and integrated annual report to members whose email addresses are registered with the company. The documents are also available on the company's website and on the website of Central Depository Services (India) Ltd. The AGM notice is also available on the website of the Stock Exchange of India Ltd. The company has informed members that the ordinary and special businesses will be transacted through voting by electronic means and there will be no physical meeting. The remote e-voting period will commence on 30th August 2026 at 9:00 AM.
BSECompany UpdateResults4d ago
IOL Chemicals & Pharmaceuticals Ltd
Schedule of analyst / investor conference call - Q1 FY27
IOL Chemicals & Pharmaceuticals Ltd is organizing an analyst/investor conference call on August 13th to discuss Q1 FY27 financial performance.
BSEOthersESG4d ago
IOL Chemicals & Pharmaceuticals Ltd
Submission of BRSR FY 2025-26
IOL Chemicals & Pharmaceuticals Ltd submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSEAGM/EGMMgmt Change4d ago
IOL Chemicals & Pharmaceuticals Ltd
Notice of 39th Annual General Meeting
IOL Chemicals & Pharmaceuticals Ltd has announced the notice of its 39th Annual General Meeting (AGM) to be held on September 2, 2026, through video conferencing. The meeting will consider the reappointment of a director, ratify the remuneration of the cost auditor, and adopt the standalone and consolidated audited financial statements for the financial year ended March 31, 2026.
BSEOthersResults4d ago
IOL Chemicals & Pharmaceuticals Ltd
Submission of Integrated Annual Report for FY 2025-26
IOL Chemicals & Pharmaceuticals Ltd has submitted its Integrated Annual Report for FY 2025-26, which includes the Notice convening the 39th Annual General Meeting scheduled for September 2, 2026.
BSEBoard MeetingResults3 Aug 2026
IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited ....
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve the Un-audited Financial Results of the Company for the quarter ended 30th June 2026.
BSECompany UpdateResults3 Aug 2026
IOL Chemicals & Pharmaceuticals Ltd
Newspaper Publication
IOL Chemicals & Pharmaceuticals Ltd will hold its 39th Annual General Meeting (AGM) through Video Conferencing (VC) or Other Audio Visual Means (OAVM) on September 2, 2026. The AGM notice and integrated annual report for FY 2025-26 will be available on the company's website and on the websites of the stock exchanges.